{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:54:22Z","timestamp":1792011262475,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82270572"],"award-info":[{"award-number":["No. 82270572"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Research Center for Genomic Resources","award":["2017B01012"],"award-info":[{"award-number":["2017B01012"]}]},{"DOI":"10.13039\/501100011230","name":"State Key Laboratory of Membrane Biology","doi-asserted-by":"publisher","award":["No.2025LMB006"],"award-info":[{"award-number":["No.2025LMB006"]}],"id":[{"id":"10.13039\/501100011230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01179-5","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:19:25Z","timestamp":1774253965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CX3CL1-CX3CR1 signaling orchestrates malignant progression of prostate cancer through luminal progenitor-macrophage crosstalk"],"prefix":"10.1007","volume":"49","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhuang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"5","key":"1179_CR1","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s13402-025-01099-w","volume":"48","author":"S Li","year":"2025","unstructured":"S. Li, Y. Tian, Y. Sun, T. Xu, W. Wang, Molecular stratification of prostate cancer through sensory perception-related multi-omics analysis reveals chemoresistant mechanisms. Cell. Oncol. (Dordr). 48(5), 1609\u20131614 (2025)","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"10437","key":"1179_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","volume":"403","author":"ND James","year":"2024","unstructured":"N.D. James, I. Tannock, J. N\u2019Dow, F. Feng, S. Gillessen, S.A. Ali et al., The lancet commission on prostate cancer: planning for the surge in cases. Lancet (London England). 403(10437), 1683\u20131722 (2024)","journal-title":"Lancet (London England)"},{"issue":"1","key":"1179_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s42003-020-01120-y","volume":"3","author":"KI Takayama","year":"2020","unstructured":"K.I. Takayama, T. Fujimura, Y. Suzuki, S. Inoue, Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. Commun. Biol. 3(1), 393 (2020)","journal-title":"Commun. Biol."},{"key":"1179_CR4","doi-asserted-by":"crossref","unstructured":"B. Zhang, M. Liu, F. Mai, X. Li, W. Wang, Q. Huang et al., Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts. J. Clin. Invest. 2024;134(14)","DOI":"10.1172\/JCI175949"},{"issue":"9","key":"1179_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41588-020-0642-1","volume":"52","author":"W Guo","year":"2020","unstructured":"W. Guo, L. Li, J. He, Z. Liu, M. Han, F. Li et al., Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat. Genet. 52(9), 908\u2013918 (2020)","journal-title":"Nat. Genet."},{"issue":"1","key":"1179_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","volume":"159","author":"WR Karthaus","year":"2014","unstructured":"W.R. Karthaus, P.J. Iaquinta, J. Drost, A. Gracanin, van R. Boxtel, J. Wongvipat et al., Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell. 159(1), 163\u2013175 (2014)","journal-title":"Cell"},{"issue":"11","key":"1179_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.trecan.2018.09.003","volume":"4","author":"D Zhang","year":"2018","unstructured":"D. Zhang, S. Zhao, X. Li, J.S. Kirk, D.G. Tang, Prostate luminal progenitor cells in development and cancer. Trends Cancer. 4(11), 769\u2013783 (2018)","journal-title":"Trends Cancer"},{"key":"1179_CR8","doi-asserted-by":"publisher","first-page":"5416923","DOI":"10.1155\/2018\/5416923","volume":"2018","author":"LTH Phi","year":"2018","unstructured":"L.T.H. Phi, I.N. Sari, Y.G. Yang, S.H. Lee, N. Jun, K.S. Kim et al., Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018, 5416923 (2018)","journal-title":"Stem Cells Int."},{"issue":"1","key":"1179_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Y. Li, Z. Wang, J.A. Ajani, S. Song, Drug resistance and cancer stem cells. Cell. Communication Signaling: CCS. 19(1), 19 (2021)","journal-title":"Cell. Communication Signaling: CCS"},{"key":"1179_CR10","doi-asserted-by":"crossref","unstructured":"E. Cendrowicz, Z. Sas, E. Bremer, T.P. Rygiel, The role of macrophages in cancer development and therapy. Cancers. (Basel). 2021;13(8)","DOI":"10.3390\/cancers13081946"},{"issue":"9","key":"1179_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"M. Bied, W.W. Ho, F. Ginhoux, C. Bl\u00e9riot, Roles of macrophages in tumor development: a Spatiotemporal perspective. Cell Mol. Immunol. 20(9), 983\u2013992 (2023)","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"1179_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/1535-7163.MCT-20-0591","volume":"20","author":"T Fujiwara","year":"2021","unstructured":"T. Fujiwara, M.A. Yakoub, A. Chandler, A.B. Christ, G. Yang, O. Ouerfelli et al., CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms Tumor-Associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment. Mol. Cancer Ther. 20(8), 1388\u20131399 (2021)","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"1179_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","volume":"23","author":"ST Barry","year":"2023","unstructured":"S.T. Barry, D.I. Gabrilovich, O.J. Sansom, A.D. Campbell, J.P. Morton, Therapeutic targeting of tumour myeloid cells. Nat. Rev. Cancer. 23(4), 216\u2013237 (2023)","journal-title":"Nat. Rev. Cancer"},{"key":"1179_CR14","doi-asserted-by":"crossref","unstructured":"B.A. Siddiqui, B.F. Chapin, S. Jindal, F. Duan, S. Basu, S.S. Yadav et al., Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). J. Immunother. Cancer. 2023;11(3)","DOI":"10.1136\/jitc-2022-006262"},{"issue":"21","key":"1179_CR15","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-20-0855","volume":"26","author":"KA Autio","year":"2020","unstructured":"K.A. Autio, C.A. Klebanoff, D. Schaer, J.S.W. Kauh, S.F. Slovin, M. Adamow et al., Immunomodulatory activity of a Colony-stimulating Factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study. Clin. Cancer Res. 26(21), 5609\u20135620 (2020)","journal-title":"Clin. Cancer Res."},{"key":"1179_CR16","doi-asserted-by":"crossref","unstructured":"H.T.T. Do, C.H. Lee, J. Cho, Chemokines and their receptors: multifaceted roles in cancer progression and potential value as cancer prognostic markers. Cancers. (Basel). 2020;12(2)","DOI":"10.3390\/cancers12020287"},{"issue":"1","key":"1179_CR17","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.4110\/in.2018.18.e5","volume":"18","author":"M Lee","year":"2018","unstructured":"M. Lee, Y. Lee, J. Song, J. Lee, S.Y. Chang, Tissue-specific role of CX(3)CR1 expressing immune cells and their relationships with human disease. Immune Netw. 18(1), e5 (2018)","journal-title":"Immune Netw."},{"key":"1179_CR18","doi-asserted-by":"crossref","unstructured":"J. Korbecki, D. Siminska, K. Kojder, S. Grochans, I. Gutowska, D. Chlubek et al., Fractalkine\/CX3CL1 in neoplastic processes. Int. J. Mol. Sci. 2020;21(10)","DOI":"10.3390\/ijms21103723"},{"issue":"4","key":"1179_CR19","first-page":"1544","volume":"53","author":"P Liu","year":"2018","unstructured":"P. Liu, Y. Liang, L. Jiang, H. Wang, S. Wang, J. Dong, CX3CL1\/fractalkine enhances prostate cancer spinal metastasis by activating the Src\/FAK pathway. Int. J. Oncol. 53(4), 1544\u20131556 (2018)","journal-title":"Int. J. Oncol."},{"issue":"1\u20132","key":"1179_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0165-5728(02)00354-5","volume":"133","author":"S Chen","year":"2002","unstructured":"S. Chen, D. Luo, W.J. Streit, J.K. Harrison, TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J. Neuroimmunol. 133(1\u20132), 46\u201355 (2002)","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"1179_CR21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1158\/0008-5472.CAN-07-1315","volume":"68","author":"WL Jamieson","year":"2008","unstructured":"W.L. Jamieson, S. Shimizu, J.A. D\u2019Ambrosio, O. Meucci, A. Fatatis, CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1\/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res. 68(6), 1715\u20131722 (2008)","journal-title":"Cancer Res."},{"issue":"14","key":"1179_CR22","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-03-3437","volume":"64","author":"SA Shulby","year":"2004","unstructured":"S.A. Shulby, N.G. Dolloff, M.E. Stearns, O. Meucci, A. Fatatis, CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res. 64(14), 4693\u20134698 (2004)","journal-title":"Cancer Res."},{"issue":"3","key":"1179_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1158\/0008-5472.CAN-08-1946","volume":"69","author":"D Castellana","year":"2009","unstructured":"D. Castellana, F. Zobairi, M.C. Martinez, M.A. Panaro, V. Mitolo, J.-M. Freyssinet et al., Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 69(3), 785\u2013793 (2009)","journal-title":"Cancer Res."},{"issue":"9","key":"1179_CR24","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41388-021-02174-w","volume":"41","author":"A DiNatale","year":"2022","unstructured":"A. DiNatale, R. Kaur, C. Qian, J. Zhang, M. Marchioli, D. Ipe et al., Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy. Oncogene. 41(9), 1337\u20131351 (2022)","journal-title":"Oncogene"},{"issue":"5","key":"1179_CR25","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.3892\/ijo.2012.1610","volume":"41","author":"L-J Xiao","year":"2012","unstructured":"L.-J. Xiao, Y.-Y. Chen, P. Lin, H.-F. Zou, F. Lin, L.-N. Zhao et al., Hypoxia increases CX3CR1 expression via HIF-1 and NF\u2013\u03baB in androgen-independent prostate cancer cells. Int. J. Oncol. 41(5), 1827\u20131836 (2012)","journal-title":"Int. J. Oncol."},{"issue":"8048","key":"1179_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","volume":"637","author":"A Lyu","year":"2025","unstructured":"A. Lyu, Z. Fan, M. Clark, A. Lea, D. Luong, A. Setayesh et al., Evolution of myeloid-mediated immunotherapy resistance in prostate cancer. Nature. 637(8048), 1207\u20131217 (2025)","journal-title":"Nature"},{"issue":"1","key":"1179_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"T. Hirz, S. Mei, H. Sarkar, Y. Kfoury, S. Wu, B.M. Verhoeven et al., Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and Spatial transcriptomic analyses. Nat. Commun. 14(1), 663 (2023)","journal-title":"Nat. Commun."},{"issue":"6490","key":"1179_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.aay0267","volume":"368","author":"WR Karthaus","year":"2020","unstructured":"W.R. Karthaus, M. Hofree, D. Choi, E.L. Linton, M. Turkekul, A. Bejnood et al., Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science. 368(6490), 497\u2013505 (2020)","journal-title":"Science"},{"issue":"2","key":"1179_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12094-020-02431-6","volume":"23","author":"Y Liu","year":"2021","unstructured":"Y. Liu, H. Ma, T. Dong, Y. Yan, L. Sun, W. Wang, Clinical significance of expression level of CX3CL1-CX3CR1 axis in bone metastasis of lung cancer. Clin. Transl Oncol. 23(2), 378\u2013388 (2021)","journal-title":"Clin. Transl Oncol."},{"issue":"33","key":"1179_CR30","doi-asserted-by":"publisher","first-page":"54136","DOI":"10.18632\/oncotarget.11250","volume":"8","author":"JF Liu","year":"2017","unstructured":"J.F. Liu, Y.T. Tsao, C.H. Hou, Fractalkine\/CX3CL1 induced intercellular adhesion molecule-1-dependent tumor metastasis through the CX3CR1\/PI3K\/Akt\/NF-kappaB pathway in human osteosarcoma. Oncotarget. 8(33), 54136\u201354148 (2017)","journal-title":"Oncotarget"},{"issue":"2","key":"1179_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.urolonc.2012.12.006","volume":"32","author":"X Yao","year":"2014","unstructured":"X. Yao, L. Qi, X. Chen, J. Du, Z. Zhang, S. Liu, Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma. Urol. Oncol. 32(2), 162\u2013170 (2014)","journal-title":"Urol. Oncol."},{"issue":"1","key":"1179_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13238-020-00786-8","volume":"12","author":"M Teng","year":"2021","unstructured":"M. Teng, S. Zhou, C. Cai, M. Lupien, H.H. He, Pioneer of prostate cancer: past, present and the future of FOXA1. Protein Cell. 12(1), 29\u201338 (2021)","journal-title":"Protein Cell."},{"issue":"1","key":"1179_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","volume":"134","author":"SJ Bensinger","year":"2008","unstructured":"S.J. Bensinger, M.N. Bradley, S.B. Joseph, N. Zelcer, E.M. Janssen, M.A. Hausner et al., LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 134(1), 97\u2013111 (2008)","journal-title":"Cell"},{"issue":"12","key":"1179_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"L. Cassetta, J.W. Pollard, Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17(12), 887\u2013904 (2018)","journal-title":"Nat. Rev. Drug Discov"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01179-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01179-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01179-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:02:29Z","timestamp":1774299749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01179-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01179-5","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with institutional guidelines and with the authorization of the Institutional Animal Care and Use Committee, Tsinghua University (Approval No. 13-LZH1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}